[Regulation of phosphorylation of tau by insulin and Ca2+ signals].
Yamamoto
Hideyuki
H
hideyuki@gpo.kumamoto-u.ac.jp
D000544:Alzheimer Disease / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D000818:Animals; D017209:Apoptosis / Q000235:genetics; D001921:Brain / Q000378:metabolism; D020013:Calcium Signaling / Q000502:physiology*; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D038362:Glycogen Synthase Kinase 3 / Q000037:antagonists & inhibitors / Q000502:physiology; D006801:Humans; D007328:Insulin / Q000502:physiology*; D008869:Microtubule-Associated Proteins / Q000378:metabolism; D016874:Neurofibrillary Tangles / Q000473:pathology; D010766:Phosphorylation; D011972:Receptor, Insulin / Q000819:agonists; D013379:Substrate Specificity; D016875:tau Proteins / Q000378:metabolism*
D004791:Enzyme Inhibitors; D007328:Insulin; D008869:Microtubule-Associated Proteins; D016875:tau Proteins; D011972:Receptor, Insulin; D054732:Calcium-Calmodulin-Dependent Protein Kinase Type 2; D017871:Calcium-Calmodulin-Dependent Protein Kinases; D038362:Glycogen Synthase Kinase 3